Davis Investment Partners, LLC Merck & Co., Inc. Transaction History

Davis Investment Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$123.8 - $132.96 $19,312 - $20,741	156 Added 8.4%	2,014 $257 Million
Q1 2024 Apr 15, 2024	SELL	$113.24 - $131.95 $13,588 - $15,833	-120 Reduced 6.07%	1,858 $236 Million
Q3 2023 Oct 10, 2023	SELL	$102.95 - $114.33 $144,130 - $160,062	-1,400 Reduced 41.44%	1,978 $205 Million
Q2 2023 Aug 01, 2023	BUY	$108.61 - $118.38 $366,884 - $399,887	3,378 New	3,378 $366 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Davis Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Davis Investment Partners, LLC with notifications on news.